718617-99-3

Basic information

• Product Name: N-{5-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-[1,3,4]oxadiazol-2-yl}-N',N'-diethyl-propane-1,3-diamine
• Synonyms: N-{5-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-[1,3,4]oxadiazol-2-yl}-N',N'-diethyl-propane-1,3-diamine
• CAS NO: 718617-99-3
• Molecular Weight: 545.346
• Mol File: 718617-99-3.mol

Chemical Properties

• CAS DataBase Reference: N-{5-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-[1,3,4]oxadiazol-2-yl}-N',N'-diethyl-propane-1,3-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-{5-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-[1,3,4]oxadiazol-2-yl}-N',N'-diethyl-propane-1,3-diamine(718617-99-3)
• EPA Substance Registry System: N-{5-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-[1,3,4]oxadiazol-2-yl}-N',N'-diethyl-propane-1,3-diamine(718617-99-3)

Safety Data

• Hazardous Substances Data: 718617-99-3(Hazardous Substances Data)

Upstream product

• 718619-68-2 4'-N-N-diethylpropylamine-1'-[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)]-semicarbazole 

Relevant articles and documents

2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase)

This paper reports a second generation MEK inhibitor. The previously reported potent and efficacious MEK inhibitor, PD-184352 (CI-1040), contains an integral hydroxamate moiety. This compound suffered from less than ideal solubility and metabolic stabilit

MEK INHIBITING OXA- AND THIA-DIAZOL-2-YL PHENYLAMINE DERIVATES

This invention provides substituted Phenyl-(2-[1,3,4]thiadiazol-2-yl-phenyl)-amine and (2-[1,3,4]Oxadiazol-2-yl-phenyl)phenyl-amine compounds which act as inhibitors of MAPKIERK Kinase ("MEK") enzymes and pharmaceutical compositions and methods for their use in immunomodulation and in the treatment and alleviation of inflammation, and proliferative diseases such as cancer and restenosis.